Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
106
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson’s disease: systematic review, meta-analysis, and economic evaluation

Zhan-Miao Yi1 Department of Pharmacy, Peking University Third Hospital;2 Department of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical Science;3 Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China
,
Ting-Ting Qiu1 Department of Pharmacy, Peking University Third Hospital;4 Public Health Department, Aix-Marseille University, Marseille, France
,
Yuan Zhang5 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
,
Na Liu6 Department of Neurology, Peking University Third Hospital, Beijing, China
&
Suo-Di Zhai1 Department of Pharmacy, Peking University Third Hospital;3 Institute for Drug Evaluation, Peking University Health Science Center, Beijing, ChinaCorrespondence[email protected]
Pages 709-719 | Published online: 16 Apr 2018

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (5)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.